Regeneron Pharmaceuticals REGN
$ 753.08
0.48%
Quarterly report 2024-Q3
added 10-31-2024
Regeneron Pharmaceuticals EV/EBITDA Ratio 2011-2024 | REGN
Annual EV/EBITDA Ratio Regeneron Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
7.63 | 13.9 | 14.5 | 16.3 | 17.8 | 24.8 | 32 | 46.5 | 35.5 | 33.6 | -45.1 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
46.5 | -45.1 | 18 |